Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department Of Translational Genomics |
RCV000171407 | SCV000221604 | likely pathogenic | not provided | criteria provided, single submitter | research | ||
Eurofins Ntd Llc |
RCV000171407 | SCV000708058 | uncertain significance | not provided | 2017-04-20 | criteria provided, single submitter | clinical testing | |
Pathology and Clinical Laboratory Medicine, |
RCV000656338 | SCV001438921 | pathogenic | Progressive familial intrahepatic cholestasis type 3 | criteria provided, single submitter | clinical testing | ||
Baylor Genetics | RCV001331237 | SCV001523233 | pathogenic | Cholestasis, intrahepatic, of pregnancy, 3 | 2019-10-25 | criteria provided, single submitter | clinical testing | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |
Center for Genomic Medicine, |
RCV000656338 | SCV003924320 | likely pathogenic | Progressive familial intrahepatic cholestasis type 3 | 2023-05-08 | criteria provided, single submitter | research | |
Rolfs Rare Disease Consulting, |
RCV000656338 | SCV004232476 | pathogenic | Progressive familial intrahepatic cholestasis type 3 | 2021-01-01 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV001331237 | SCV004804971 | likely pathogenic | Cholestasis, intrahepatic, of pregnancy, 3 | 2024-03-17 | criteria provided, single submitter | research | |
Biochemical Molecular Genetic Laboratory, |
RCV000656338 | SCV000778301 | pathogenic | Progressive familial intrahepatic cholestasis type 3 | 2018-03-14 | no assertion criteria provided | clinical testing |